{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:27:26Z","timestamp":1790882846169,"version":"4.1.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"13","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Inherited or de novo germ line heterozygous mutations in the gene encoding the transcription factor GATA2 lead to its deficiency. This results in a constellation of clinical features including nontuberculous mycobacterial, bacterial, fungal, and human papillomavirus infections, lymphedema, pulmonary alveolar proteinosis, and myelodysplasia. The onset, or even the presence, of disease is highly variable, even in kindreds with the identical mutation in GATA2. The clinical manifestations result from the loss of a multilineage progenitor that gives rise to B lymphocytes, monocytes, natural killer cells, and dendritic cells, leading to cytopenias of these lineages and subsequent infections. The bone marrow failure is typically characterized by hypocellularity. Dysplasia may either be absent or subtle but typically evolves into multilineage dysplasia with prominent dysmegakaryopoiesis, followed in some instances by progression to myeloid malignancies, specifically myelodysplastic syndrome, acute myelogenous leukemia, and chronic myelomonocytic leukemia. The latter 3 malignancies often occur in the setting of monosomy 7, trisomy 8, and acquired mutations in ASXL1 or in STAG2. Importantly, myeloid malignancy may represent the primary presentation of disease without recognition of other syndromic features. Allogeneic hematopoietic stem cell transplantation (HSCT) results in reversal of the phenotype. There remain important unanswered questions in GATA2 deficiency, including the following: (1) Why do some family members remain asymptomatic despite harboring deleterious mutations in GATA2? (2) What are the genetic changes that lead to myeloid progression? (3)\u00a0What causes the apparent genetic anticipation? (4) What is the role of preemptive HSCT?<\/jats:p>","DOI":"10.1182\/blood.2022017764","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:07:11Z","timestamp":1669928831000},"page":"1524-1532","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["The spectrum of GATA2 deficiency syndrome"],"prefix":"10.1182","volume":"141","author":[{"given":"Katherine R.","family":"Calvo","sequence":"first","affiliation":[{"name":"1Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-7209","authenticated-orcid":false,"given":"Dennis D.","family":"Hickstein","sequence":"additional","affiliation":[{"name":"2Immune Deficiency \u2013 Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2023110216013252000_bib1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2023110216013252000_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"2023110216013252000_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ajmg.a.33445","article-title":"Emberger syndrome\u2014primary lymphedema with myelodysplasia: report of seven new cases","volume":"152A","author":"Mansour","year":"2010","journal-title":"Am J Med Genet"},{"issue":"10","key":"2023110216013252000_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"2023110216013252000_bib5","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2023110216013252000_bib6","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2023110216013252000_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"issue":"4","key":"2023110216013252000_bib8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.chest.2021.05.046","article-title":"Pulmonary manifestations of GATA2 deficiency","volume":"160","author":"Marciano","year":"2021","journal-title":"Chest"},{"issue":"1","key":"2023110216013252000_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciw160","article-title":"Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers","volume":"63","author":"Cohen","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2023110216013252000_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2023110216013252000_bib11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"19","key":"2023110216013252000_bib12","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2023110216013252000_bib13","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1172\/JCI61623","article-title":"Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity","volume":"122","author":"Johnson","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2023110216013252000_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2023110216013252000_bib15","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41375-020-0899-5","article-title":"Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency","volume":"34","author":"Kozyra","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"2023110216013252000_bib16","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1111\/bjh.16819","article-title":"A\u00a0synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability","volume":"190","author":"Fox","year":"2020","journal-title":"Br J Haematol"},{"issue":"24","key":"2023110216013252000_bib17","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/bloodadvances.2021005217","article-title":"GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"2023110216013252000_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12185-021-03130-w","article-title":"A\u00a0novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome","volume":"114","author":"Nakazawa","year":"2021","journal-title":"Int J Hematol"},{"issue":"2","key":"2023110216013252000_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/scientificamerican0891-86","article-title":"Smart genes","volume":"265","author":"Beardsley","year":"1991","journal-title":"Sci Am"},{"issue":"4","key":"2023110216013252000_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI0215043","article-title":"Transcription factor haploinsufficiency: when half a loaf is not enough","volume":"109","author":"Seidman","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"2023110216013252000_bib21","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1182\/blood.V89.10.3636","article-title":"Transcription factor GATA-2 is required for proliferation\/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood"},{"issue":"6494","key":"2023110216013252000_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"issue":"4","key":"2023110216013252000_bib23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/cas.13959","article-title":"GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice","volume":"110","author":"Harada","year":"2019","journal-title":"Cancer Sci"},{"issue":"3","key":"2023110216013252000_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41375-020-0942-6","article-title":"Gata2 -77 enhancer regulates adult hematopoietic stem cell survival","volume":"35","author":"You","year":"2021","journal-title":"Leukemia"},{"issue":"10","key":"2023110216013252000_bib25","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1172\/JCI61619","article-title":"Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning","volume":"122","author":"Lim","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"2023110216013252000_bib26","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V86.8.3173.3173","article-title":"The expression pattern of erythrocyte\/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia","volume":"86","author":"Shimamoto","year":"1995","journal-title":"Blood"},{"issue":"2","key":"2023110216013252000_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/leu.2009.263","article-title":"Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis","volume":"24","author":"Bullinger","year":"2010","journal-title":"Leukemia"},{"issue":"8","key":"2023110216013252000_bib28","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.leu.2402517","article-title":"GATA-1 and GATA-2 gene expression is related to the severity of dysplasia in myelodysplastic syndrome","volume":"16","author":"Fadilah","year":"2002","journal-title":"Leukemia"},{"issue":"4","key":"2023110216013252000_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.hoc.2018.04.004","article-title":"Germline GATA2 mutation and bone marrow failure","volume":"32","author":"McReynolds","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"2023110216013252000_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2023110216013252000_bib31","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2019001352","article-title":"Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency","volume":"4","author":"Wu","year":"2020","journal-title":"Blood Adv"},{"issue":"23","key":"2023110216013252000_bib32","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/bloodadvances.2018017137","article-title":"GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells","volume":"2","author":"Jung","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"2023110216013252000_bib33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/JLB.2A1220-824R","article-title":"miR-181c regulates MCL1 and cell survival in GATA2 deficient cells","volume":"111","author":"Wang","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2023110216013252000_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2023110216013252000_bib35","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2011.041152","article-title":"Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications","volume":"96","author":"Calvo","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"2023110216013252000_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Novakova","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"2023110216013252000_bib37","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2023110216013252000_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.2007.06537.x","article-title":"World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes","volume":"137","author":"Bernasconi","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"2023110216013252000_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3324\/haematol.2011.054361","article-title":"Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival","volume":"97","author":"Bodor","year":"2012","journal-title":"Haematologica"},{"issue":"8","key":"2023110216013252000_bib40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"2023110216013252000_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2023110216013252000_bib42","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","article-title":"ASXL1 and STAG2 are common muations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome","volume":"6","author":"West","year":"2022","journal-title":"Blood Adv"},{"issue":"23","key":"2023110216013252000_bib43","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood.2021012781","article-title":"Association of unbalanced translocation der(1;7) with germline GATA2 mutations","volume":"138","author":"Kozyra","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2023110216013252000_bib44","doi-asserted-by":"crossref","first-page":"e113088","DOI":"10.1371\/journal.pone.0113088","article-title":"MDM4 overexpressed in acute myeloid leukemia patients with complex karyotype and wild-type TP53","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"7180","key":"2023110216013252000_bib45","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nature06634","article-title":"Cohesin mediates transcriptional insulation by CCCTC-binding factor","volume":"451","author":"Wendt","year":"2008","journal-title":"Nature"},{"issue":"5","key":"2023110216013252000_bib46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.stem.2019.08.003","article-title":"Cohesin members stag1 and stag2 display distinct roles in chromatin accessibility and topological control of HSC self-renewal and differentiation","volume":"25","author":"Viny","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2023110216013252000_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V30.2.251.251","article-title":"Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \"hypoplastic\" leukemia have in common?","volume":"30","author":"Dameshek","year":"1967","journal-title":"Blood"},{"issue":"2","key":"2023110216013252000_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood-2004-08-2989","article-title":"Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis","volume":"106","author":"Rodrigues","year":"2005","journal-title":"Blood"},{"key":"2023110216013252000_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2018.11.013","article-title":"MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations","volume":"76","author":"McReynolds","year":"2019","journal-title":"Leuk Res"},{"key":"2023110216013252000_bib50","first-page":"100176","article-title":"Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation","volume":"12","author":"McReynolds","year":"2019","journal-title":"Leuk Res Rep"},{"issue":"1","key":"2023110216013252000_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.25684","article-title":"Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management","volume":"95","author":"Patnaik","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"2023110216013252000_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.leukres.2008.08.022","article-title":"Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium","volume":"33","author":"Chan","year":"2009","journal-title":"Leuk Res"},{"issue":"3","key":"2023110216013252000_bib53","doi-asserted-by":"crossref","first-page":"e28865","DOI":"10.1002\/pbc.28865","article-title":"Venetoclax\/decitabine for a pediatric patient with chronic myelomonocytic leukemia","volume":"68","author":"Molina","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2023110216013252000_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2017-04-736421","article-title":"How I treat chronic myelomonocytic leukemia","volume":"130","author":"Solary","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2023110216013252000_bib55","doi-asserted-by":"crossref","first-page":"E203","DOI":"10.1002\/ajh.25853","article-title":"Special considerations in the management of patients with myelodysplastic myndrome \/ myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic","volume":"95","author":"Patnaik","year":"2020","journal-title":"Am J Hematol"},{"issue":"10","key":"2023110216013252000_bib56","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pbc.26084","article-title":"Acute lymphoblastic leukemia in a patient with MonoMAC syndrome\/GATA2 haploinsufficiency","volume":"63","author":"Koegel","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2023110216013252000_bib57","doi-asserted-by":"crossref","first-page":"e27649","DOI":"10.1002\/pbc.27649","article-title":"A\u00a0unique phenotype of T-cell acute lymphoblastic leukemia in a patient with GATA2 haploinsufficiency","volume":"66","author":"Esparza","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"7380","key":"2023110216013252000_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"7188","key":"2023110216013252000_bib59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature06839","article-title":"Adult T-cell progenitors retain myeloid potential","volume":"452","author":"Wada","year":"2008","journal-title":"Nature"},{"issue":"2","key":"2023110216013252000_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"issue":"12","key":"2023110216013252000_bib61","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.bbmt.2014.08.004","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"20","author":"Grossman","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2023110216013252000_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2020.12.028","article-title":"Hematopoietic cell transplantation and outcomes related to human papillomavirus disease in GATA2 deficiency","volume":"27","author":"Parta","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"13","key":"2023110216013252000_bib63","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2023110216013252000_bib64","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41375-018-0134-9","article-title":"GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS\/AML","volume":"32","author":"Al Seraihi","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2023110216013252000_bib65","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a busulfan-based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2023110216013252000_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjh.17840","article-title":"Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency","volume":"196","author":"Nichols-Vinueza","year":"2022","journal-title":"Br J Haematol"},{"issue":"12","key":"2023110216013252000_bib67","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood-2018-02-826461","article-title":"HSCT for GATA2 deficiency across the pond","volume":"131","author":"Hickstein","year":"2018","journal-title":"Blood"},{"issue":"12","key":"2023110216013252000_bib68","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2017-10-811489","article-title":"In\u00a0vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction","volume":"131","author":"Tholouli","year":"2018","journal-title":"Blood"},{"issue":"18","key":"2023110216013252000_bib69","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood-2018-07-861070","article-title":"Donor-derived MDS\/AML in families with germline GATA2 mutation","volume":"132","author":"Galera","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2023110216013252000_bib70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12185-020-02980-0","article-title":"Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation","volume":"113","author":"Sakata","year":"2021","journal-title":"Int J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/13\/1524\/2087726\/blood_bld-2022-017764-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/13\/1524\/2087726\/blood_bld-2022-017764-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:02:19Z","timestamp":1698940939000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/13\/1524\/493407\/The-spectrum-of-GATA2-deficiency-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":70,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,3,30]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017764","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}